Effect of Oral Nitrates on All-Cause Mortality and Hospitalization in Heart Failure Patients with Reduced Ejection Fraction: A Propensity-Matched Analysis


Ural D., Kandemir A., Karauzum K., BAYDEMİR C., Karauzum I. Y., Bozyel S., ...More

JOURNAL OF CARDIAC FAILURE, vol.23, no.4, pp.286-292, 2017 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 23 Issue: 4
  • Publication Date: 2017
  • Doi Number: 10.1016/j.cardfail.2017.02.006
  • Journal Name: JOURNAL OF CARDIAC FAILURE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.286-292
  • Kocaeli University Affiliated: Yes

Abstract

Background: Hydralazine-nitrate combination is recommended for patients with heart failure with reduced ejection fraction (HFrEF)/systolic heart failure who are symptomatic despite guideline-directed medical therapy (GDMT). Use of nitrates alone for this indication is not well-established. This study aims to evaluate the effect of oral nitrates on all-cause mortality and hospitalization in HFrEF patients using GDMT.